Description
The Arctic Front Advance Pro™ cardiac cryoablation catheter is part of a family of cryoballoon catheters anatomically designed for use with the Achieve™ mapping catheters, the FlexCath Contour™ steerable sheath, the FlexCath Cross™ transeptal solution, and the Nitron CryoConsole™ cardiac cryoablation system to enable PVI. Over 1.4 million patients worldwide have been treated with the Medtronic cryoballoon.
The cryoballoon:
- Is an anatomical approach for PVI, creating long, contiguous circumferential lesions surrounding the pulmonary vein1,2
- Has shorter, more predictable procedure times,3 which may allow you to treat more patients in the same amount of time
With more than 17 years of clinical experience, over 2,000 peer-reviewed articles,4 and backed by sound clinical evidence, the Arctic Front™ family is the leader in cryoablation technology offering a safe, efficient, and consistent way to treat AF.
- Kenigsberg DN, Martin N, Lim HW, Kowalski M, Ellenbogen KA. Quantification of cryoablation zone demarcated by pre- and post-procedural electroanatomical mapping in atrial fibrillation patients using the 28 mm second generation cryoballoon. Heart Rhythm. 2015;12(2):283–290.
- Okumura Y, Watanabe I, Iso K, et al. Mechanistic insights into durable pulmonary vein isolation achieved by second-generation cryoballoon ablation. J Atr Fibrillation. 2017;9(6):1538.
- Kuck KH, Brugada J, Fürnkranz A, et al. Cryoballoon or radiofrequency ablation for paroxysmal atrial fibrillation. N Engl J Med. 2016;374(23):2235–2245.
- 1,843 publications (pubmed 25OCT2022,"cryoablation“+“atrial“+“fibrillation“), 95% released 2000–2022, 1,737 publications 2003.
Not what you're looking for?
Find more information, including other available configurations, for Arctic Front Advance Pro™ cardiac cryoablation catheter.